News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.
Promising Reports from First-in-Human Trial for ADC SCLC
Report Details Bispecific Antibody Drug Conjugate Market Ripe with Key Partnerships
Clonogenic Hepatocytes are Important Targets for Paediatric Gene Therapies, say Researchers
Double Strike for Akeso’s mAbs in Phase III Treating Atopic Dermatitis & Ankylosing Spondylitis
Natural Enzyme ‘Staples’ Peptides into Macrocycles, Expanding Therapeutic Potential
Scientists Untangle RNA Clusters Found in Huntington’s & ALS Brains
First Patient Given “Off-The-Shelf” CAR T Cell Therapy for MS
Cell 2025: Connecting the Full Value Chain to Shape the Future of Cell & Gene Therapies
Encouraging Updates in mRNA HIV Vaccine Clinical Trial
ProteinQure’s Novel Peptide-Drug Conjugate Cleared to Enter the Clinic in US and Canada
Autolus’s Novel CAR T Therapy Aucatzyl Granted European Marketing Approval
Zymeworks Granted IND Clearance for Novel ADC, ZW251
Multiple Myeloma mRNA Cancer Vaccine Slows Tumour Growth in Mice
Promising Phase I Results from Osteoarthritis Gene Therapy
Scientists Find ‘Virtual Memory T Cells’, a Critical Component of Infant Immunity
TandemAI and Perpetual Medicines Merge to Form New Small Molecule and Peptide Discovery
In Vivo CAR T Proven Effective and Safe in Mice, says Stanford Study
Promising Results from Phase II Neoantigen Peptide Vaccine Trial with CLERT
Intranasal mAbs Act as ‘Molecular Shield’ Against Pollen in Potential Hay Fever Treatment
Potential ‘Universal Cancer Vaccine’ Tested by Florida Researchers in Mice
AAV Gene Therapy Restores Hearing in Deaf Patients